OPR - Delayed Quote • USD PCVX Sep 2024 40.000 put (PCVX240920P00040000) Follow 2.0000 0.0000 (0.00%) As of April 23 at 3:27 PM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for PCVX240920P00040000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PCVX Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares 30 Biggest Biotechnology Companies in the World Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants Q4 2023 Vaxcyte Inc Earnings Call Vaxcyte, Inc. (PCVX) Is Up 2.14% in One Week: What You Should Know Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2023 Earnings Call Transcript Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update The Zacks Analyst Blog Highlights HEICO, Constellation Energy, Inter Parfums, Apellis Pharmaceuticals and Vaxcyte Why Vaxcyte (PCVX) Might Surprise This Earnings Season 5 Stocks to Buy That Are Poised to Beat on Earnings This Week
